3/6/24 16:49 | 3/4/24 | ACHV | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | P.d | 46 | 4.59 | 0 | 10 | 35 | 39 | D | | | | | | | | | | | | | | |
3/6/24 16:43 | 3/4/24 | ACHV | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P.d | 46 | 4.59 | 0 | 10 | 15 | 77 | D | | | | | | | | | | | | | | |
6/1/23 17:42 | 5/30/23 | ACHV | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P | 28 | 5.50 | 0 | 5 | 8 | 67 | D | | | | | | | | | | | | | | |
11/21/22 14:27 | 11/18/22 | ACHV | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P.d | 0 | 0.00 | 0 | 22 | 147 | 37 | D | | | | | | | | | | | | | | |
5/27/21 16:10 | 5/27/21 | ACHV | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P | 42 | 7.00 | 0 | 6 | 999% | 6 | D | | | | | | | | | | | | | | |
6/13/19 17:15 | 6/11/19 | ACHV | Health | Diagn | In Vitro & In Vivo Diagnostic | Armistice Capital, LLC | NY | T | | P | 49 | 3.80 | 0 | 13 | 1 | 1,688 | M | | | | | | | | | | | | | | |
5/28/19 06:01 | 5/23/19 | ACHV | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | CB,CEO | P | 63 | 3.61 | 0 | 18 | 8 | 237 | D | | | | | | | | | | | | | | |
8/16/12 14:31 | 8/15/12 | OGXI | Health | Diagn | In Vitro & In Vivo Diagnostic | Goldstein Jack | WA | D | | P | 14 | 14.38 | 0 | 1 | New | 1 | D | 3 | 21 | 2 | 15 | 0 | 2 | -1 | -1 | 1 | 0 | -1 | -18 | -16 | -40 |
6/4/12 12:39 | 6/1/12 | OGXI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mattingly Martin A | WA | D | | P.d | 12 | 12.46 | 1 | 1 | New | 1 | D | -10 | -29 | 9 | -18 | 8 | 0 | 0 | -1 | -3 | -2 | 11 | 7 | -1 | -25 |
8/9/11 19:14 | 8/9/11 | OGXI | Health | BioPrd | Biological Products, (No Diag | Parker H Stewart | WA | D | | P | 30 | 10.09 | 1 | 3 | New | 3 | D | -66 | -32 | -35 | -34 | -41 | -36 | -28 | -22 | -3 | 7 | -1 | 13 | 37 | 30 |
11/10/10 12:27 | 11/9/10 | OGXI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lawrence Cameron William | A1 | O | Principa | P | 10 | 15.73 | 3 | 1 | 23 | 4 | I | 445 | -48 | -20 | 5 | 12 | -10 | 0 | -1 | 0 | 1 | 2 | 1 | -2 | -20 |
11/17/08 13:44 | 8/26/08 | OGXI | Health | Diagn | In Vitro & In Vivo Diagnostic | Anderson Stephen Charles | A1 | O | CFO,Secr | P.a | 68 | 6.77 | 0 | 10 | 71 | 24 | I | -98 | -69 | -60 | -52 | -25 | -20 | -8 | -13 | 6 | 0 | 133 | 44 | 455 | 999 |
11/14/08 12:18 | 11/12/08 | OGXI | Health | Diagn | In Vitro & In Vivo Diagnostic | Anderson Stephen Charles | A1 | O | CFO,Secr | P.am | 7 | 2.43 | 0 | 3 | 30 | 13 | I | -98 | -69 | -59 | -46 | -33 | -12 | -4 | -6 | -2 | -2 | 147 | 18 | 385 | 999 |
11/13/08 18:53 | 11/12/08 | OGXI | Health | Diagn | In Vitro & In Vivo Diagnostic | Anderson Stephen Charles | A1 | O | CFO,Secr | P.m | 7 | 2.43 | 0 | 3 | | 2 | I | -98 | -67 | -58 | -49 | -34 | -15 | -6 | -13 | -2 | -2 | 190 | 60 | 230 | 999 |
9/29/08 16:32 | 9/26/08 | OGXI | Health | Diagn | In Vitro & In Vivo Diagnostic | Cormack Scott Daniel | A1 | DO | P,CEO | P | 20 | 3.99 | 0 | 5 | 383 | 6 | D | -95 | -65 | -40 | -20 | -14 | -34 | -12 | -5 | 0 | 3 | -14 | 16 | 17 | 858 |
8/27/08 19:14 | 8/26/08 | OGXI | Health | Diagn | In Vitro & In Vivo Diagnostic | Anderson Stephen Charles | A1 | O | CFO,Secr | P | 68 | 6.77 | 0 | 10 | New | 10 | I | -92 | -90 | -25 | 32 | 42 | 48 | 48 | 38 | -8 | -14 | -37 | -65 | -43 | 399 |
11/16/06 18:01 | 11/16/06 | SNUS | Health | Diagn | In Vitro & In Vivo Diagnostic | Dunbar George W Jr | WA | D | | P | 10 | 5.45 | 0 | 2 | 117 | 3 | D | | | | | | | | | | | | | | |
2/23/04 17:25 | 2/19/04 | SNUS | Health | Diagn | In Vitro & In Vivo Diagnostic | Sac Capital Advisors LLC | CT | T | | P | 1,584 | 8.56 | 0 | 185 | 15 | 1,420 | I | | | | | | | | | | | | | | |